Alamar Biosciences' IPO
Listed Apr 17, 2026 at $17 on Nasdaq as ALMR.
Today 79% above its $17 offer price; its first day closed +29.4%.
Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.
What does Alamar Biosciences do?
“We are a commercial-stage proteomics company establishing a gold standard in protein detection and analysis.”
| Fact | Alamar Biosciences |
|---|---|
| Headquarters | Fremont, California |
| Employees | 99, as of December 31, 2025 |
| Website | alamarbio.com |
What is the offering?
Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.
| Fact | Alamar Biosciences |
|---|---|
| Shares offered | 11,250,000 |
| Offer price | $17 a share |
| Raised at that price | $191 million |
| Underwriters' discount | $13.4 million |
| Net proceeds the company expects | About $172 million |
| Underwriters' option | 1,687,500 more shares |
| Underwriters | J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners, and Stifel |
| Exchange | Nasdaq Global Select Market, as ALMR |
What the filing says about its money
| Fact | Alamar Biosciences |
|---|---|
| Total revenue | $74.2 million, year to December 31, 2025 |
| Net loss | $29.2 million, year to December 31, 2025 |
| Last preferred stock | Series C preferred |
Every date of Alamar Biosciences' IPO
| What | Day |
|---|---|
| Registration filed | Mar 27, 2026 |
| Exchange registration filed | Apr 15, 2026 |
| Priced | Apr 16, 2026 |
| First trade | Apr 17, 2026 |
| Declared effective by the SEC | Apr 20, 2026 |
| Lock-up ends | Oct 13, 2026 |
How did its first days trade?
From its daily bars, each close against its $17 offer price.
| Day | Open | Close | From the offer |
|---|---|---|---|
| Apr 17 | $22.60 | $22 | +29.4% |
| Apr 20 | $22.34 | $22 | +29.4% |
| Apr 21 | $21.75 | $23.23 | +36.6% |
| Apr 22 | $23.24 | $24.27 | +42.8% |
| Apr 23 | $24.55 | $24.27 | +42.8% |
What is Alamar Biosciences' Quality Score?
Below Average
ALMR's page, with every reason behind its scoreThe other IPOs expected
| Company | Price |
|---|---|
| $19 to $21 | |
| $15 to $17 | |
| $15 to $17 | |
| $7 | |
| $5 to $7 |
Alamar Biosciences IPO questions
When is Alamar Biosciences' IPO?
Listed Apr 17, 2026 at $17 on Nasdaq as ALMR.
What is Alamar Biosciences' IPO price?
Alamar Biosciences' IPO priced at $17 a share, per its final prospectus of Apr 17, 2026.
How many shares is Alamar Biosciences selling?
11,250,000 shares, and the underwriters may buy 1,687,500 more, per its final prospectus (424B4).
Who are the underwriters?
J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners, and Stifel, as the prospectus's cover names them.
When does the lock-up end?
Alamar Biosciences' IPO lock-up ends Oct 13, 2026. Its final prospectus says: “.”
Does Breakaway rate Alamar Biosciences?
Alamar Biosciences has a Quality Score of 0 today. The score counts the 14 chart checks and the company's filings; a check that needs more history than a new stock has waits for it.
Can Breakaway say where Alamar Biosciences' price will go?
No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every new listing, ranked live, free. No account.
See all 16 new listings rankedSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.